Results 221 to 230 of about 255,505 (337)

Predicting the Risk for Pathological Fracture in Bone Metastases. [PDF]

Curr Oncol
Altsitzioglou P, Tsukamoto S, Errani C, Tanaka Y, Mavrogenis AF.   +4 more
europepmc   +1 more source

Changing landscape of optical imaging in skeletal metastases [PDF]

, 2019
Cho, Nicholas, Shokeen, Monica
core   +1 more source

Photoacoustic Microscopy for Multiscale Biological System Visualization and Clinical Translation

Advanced Science, EarlyView.
Photoacoustic microscopy (PAM) is a powerful biomedical imaging tool renowned for its non‐invasiveness and high resolution. This review synthesizes recent technological advances and highlights their broad applications from cellular and organ‐level to whole‐animal imaging.
Tingting Wang, Jiali Chen, Liming Nie, Honghui Li   +3 more
wiley   +1 more source

Bone metastases from neuroendocrine neoplasms: Results of an Italian nationwide survey of natural history and management. [PDF]

J Neuroendocrinol
Fazio N, Maisonneuve P, Frezza AM, Ranallo N, Ibrahim T, La Salvia A, Brizzi MP, De Divitiis C, Tafuto S, Pusceddu S, Marconcini R, Cives M, Ferrari C, Campana D, De Lisi D, Santini D, Faggiano A, Modica R, Massironi S, Bianchi A, Panzuto F, Antonuzzo L, Pellegrini E, Amoroso V, Puliafito I, Merola E, Silvestris N, Grana CM, Spada F.   +28 more
europepmc   +1 more source

Mapping CSC‐Mediated Ovarian Cancer Chemoresistance via CXCR4‐PET to Guide Precision Cisplatin Re‐Sensitization Therapy

Advanced Science, EarlyView.
CXCR4 functions as a potential cancer stem cell‐associated marker linked to chemoresistance in ovarian cancer, and an inhibitor of CXCR4, AMD3100, can enhance the cytotoxic response to cisplatin. Based on these findings, [68Ga]Ga‐Pentixafor positron emission tomography enables selective visualization of CXCR4‐high ovarian cancer, while AMD3100 combined
Lixia Feng, Simei Zhao, Zheng Wei, Wenwen Wang, Feiquan Ying, Lin Huang, Mengna Zhu, Mengqing Chen, Qiang Yang, Si Sun, Dawei Jiang, Lingling Gao, Jing Cai   +12 more
wiley   +1 more source

Real-life use of bone-targeting agents for bone metastases in France between 2009 and 2018: Results of the OPTIMOS study. [PDF]

J Bone Oncol
Confavreux CB, Bouvard B, Girard N, Bosco-Levy P, Marchal C, Nolin M, Lehmann E, Desameric G, Belhassen M.   +8 more
europepmc   +1 more source

Single‐Cell Dissection of Tumor‐Infiltrating Lymphocytes Reveals Cellular Architecture Predictive of Therapeutic Efficacy in Acral Melanoma

Advanced Science, EarlyView.
Autologous tumor‐infiltrating lymphocyte (TIL) therapy shows promising efficacy in acral melanoma, yet determinants of durable response remain unclear. By integrating single‐cell transcriptomics and TCR sequencing, this study reveals that TIL products enriched for T follicular helper and intermediate exhausted T cells establish persistent clonal ...
Chao Zhang, Wanyi Xiao, Hongru Shen, Fenge Li, Ting Li, Weihong Zhang, Haotian Liu, Ziwei Gao, Hongyu Wang, Xiubao Ren, Kexin Chen, Xiangchun Li, Jilong Yang   +12 more
wiley   +1 more source

Oxidation-activated nanotherapy boosts tumor immunity and disrupts tumor-nerve crosstalk to combat bone metastases and cancer pain. [PDF]

Sci Adv
Zhang Z, Chen P, Zheng Y, Li M, Zhao L, Fu Z, Zhou Y, Zhang T, Sun X, Zhu D, Shen Y, Fan S, Liu X, Xiang J.   +13 more
europepmc   +1 more source

Engineering Immune Cell to Counteract Aging and Aging‐Associated Diseases

Advanced Science, EarlyView.
This review highlights a paradigm shift in which advanced immune cell therapies, initially developed for cancer, are now being harnessed to combat aging. By engineering immune cells to selectively clear senescent cells and remodel pro‐inflammatory tissue microenvironments, these strategies offer a novel and powerful approach to delay age‐related ...
Jianhua Guo, Lanjie Lei, Ying Jin, Lan Su, Shumao Cui, Liyun Shi   +5 more
wiley   +1 more source

Impact of surgery on survival in TNBC with bone metastases only: a propensity score-matched SEER database analysis. [PDF]

Discov Oncol
Cai S, Lu Q, Wei L, Zhang Z, Chen X, Gu Y, Yu Y, Zhang L.   +7 more
europepmc   +1 more source